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Abstract
Introduction: Cerebrospinal fluid (CSF) from extra-ventricular drainage (EVD) systems is routinely analysed to diagnose EVD–related bacterial 
meningitis. We investigated the effect of time delay and sample processing on cell count and basic biochemistry results in EVD CSF to define optimal 
turnaround time and whether manual and automated cell counting are comparable in such samples.
Materials and methods: In total, 32 EVD CSF samples were analysed. Baseline testing included cell counting (Fuchs-Rosenthal chamber and 
Sysmex XE5000) and biochemistry analyses (glucose, lactate, proteins). Manual cell counting was also performed at intervals of 61-90 and 91-150 
minutes from baseline in the residual sample. Biochemistry analyses were performed in samples before and after centrifugation at baseline and at 
91-150 minutes interval.
Results: At 91-150 minutes total cell count (P < 0.001), large lymphocytes (P = 0.007), neutrophils (P < 0.001) and phagocytes (P = 0.006) obtai-
ned by manual counting decreased and the number of disintegrated cells count increased (P = 0.016) compared to the baseline values. Considering 
method comparison, proportional difference between methods for all cell (sub)groups was obtained, whereas polymorphonuclears also showed the 
constant difference (y = 11.21 + 1.22x). Compared to centrifuged CSF, lower concentration of glucose and lactates were obtained in uncentrifuged 
samples (P < 0.001) at baseline. 
Conclusions: Manual cell counting should be performed within 60 minutes as any delay can alter results. The same counting technique should be 
used to obtain longitudinally assessable results. Biochemistry tests are stable in uncentrifuged CSF up to 2.5 hours.
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Cerebrospinal fluid (CSF) assays are an integral 
part of diagnostics of neurological diseases, espe-
cially in the emergency neurological patients. In 
such cases, it is imperative that the results are 
available as soon as possible to assist in diagnosis 
and further patient treatment. 
Extraventricular drainage (EVD) system is indicat-
ed for the management of patients who suffered 
subarachnoid or intracranial haemorrhage, hydro-
cephalus, shunt malfunction or have a tumour 
(1,2). Such patients have a higher risk of associated 
central nervous system (CNS) infection (1,3,4). As 
clinical signs are not indicative of CNS infection 
and because complete neurological evaluation is 
impossible in ventilated and sedated patients, 
sampling from EVD system and laboratory analysis 
of CSF is often performed to diagnose external 
drainage–related bacterial meningitis at an early 
stage (5). 
In patients with bacterial meningitis without EVD 
system, CSF pleocytosis, low glucose, elevated lac-
tate and proteins are highly indicative of the dis-
ease (1,6). However, in patients with EVD systems, 
the composition of CSF is different due to the un-
derlying condition or the effects of neurosurgical 
processes (1,7). Although CSF culture remains to 
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be the gold standard in the diagnosis of bacterial 
meningitis, numerous studies have evaluated the 
potential predictive value of CSF routine laborato-
ry tests for predicting EVD associated ventriculitis 
(2,3,5,7-10).
Clinical and Laboratory Standards Institute (CLSI) 
H56-A guidelines on analysis of cellular compo-
nents in body fluids recommend that cells should 
be natively counted using a counting chamber. 
Cell counting should be performed as soon as pos-
sible because of rapid in vitro decomposition of 
cells (11). Furthermore, metabolites, such as glu-
cose and lactate, are highly dependent on in vitro 
metabolic processes (12). 
According to the consensus protocol for the stand-
ardization of CSF collection, the CSF samples ob-
tained by lumbar puncture (LP) should be pro-
cessed as soon as possible but the document also 
acknowledges that processing of CSF samples 
within an hour is not a common practice in most 
laboratories. Thus, the main recommendation is 
that sample processing should be done within a 
time delay of 1.5 hours (± 30 minutes) (13). At pre-
sent, there are no recommendations about opti-
mal processing of the EVD samples. Samples of 
CSF from EVD system are partially different from 
lumbar CSF samples because they often contain a 
high number of various cells and cell debris. There-
fore, manual counting can be tedious and delay 
the reporting of results (14,15). For these reasons, 
the automated method for cell counting would be 
preferable to manual counting, but there are no 
recommendations whether both methods can be 
used simultaneously without restriction for sam-
ples collected from EVDs. Furthermore, processing 
CSF samples before analysis inevitably postpone 
results reporting due to the time needed for cen-
trifugation. 
The aim of this study was to investigate the effect 
of time delay and sample processing on cell count 
and basic biochemistry results in CSF obtained 
from EVD systems to define optimal turnaround 
time (TAT) for these samples. Additionally, we have 
compared automated and manual counting meth-
ods to investigate whether both methods could 
be performed interchangeably in EVD samples.
Materials and methods
Materials
This prospective experimental study was per-
formed from October 2016 to January 2017 in De-
partment of Laboratory Diagnostics, University 
Hospital Centre Zagreb, Croatia. Consecutive CSF 
samples collected from EVD systems using stand-
ard collection procedure of adult patients from 
neurological intensive care units, and delivered to 
the laboratory for routine processing in the morn-
ing hours (from 7 to 11 am) with sufficient sample 
volume (> 2 mL) were included (16). In total, we 
have analysed 32 CSF samples collected from EVD. 
Extremes in cell count measurement were identi-
fied visually by scatter plot analysis if values were 
unevenly distributed across the concentration 
range. Two samples were therefore excluded from 
further cell count method comparison analysis as 
these samples had extremely high cell number, 
which would influence Passing-Bablok regression 
analysis. All samples were anonymous samples 
collected for standard laboratory practice and all 
testing regarding sample stability was performed 
on residual samples. No additional sample was 
collected specifically for this study.  
For this type of study, informed consent is implied 
and ethical committee approval is not necessary. 
The study was performed according to the re-
quirements of the Declaration of Helsinki. 
Methods
Upon sample admission, EVD CSF was thoroughly 
mixed to achieve a homogenized sample. Routine 
testing of CSF included manual cell counting and 
biochemistry analyses in centrifuged sample. Ad-
ditionally, automated cell counting and biochem-
istry analysis in uncentrifuged sample were per-
formed. These results were used as baseline values 
for this study. The residual materials of EVD CSF 
were used for testing the effect of time delay and 
sample processing on manual cell count and bio-
chemistry tests (Figure 1). The tube with uncentri-
fuged residual sample was kept closed at room 
temperature (range 22-26 °C) and was used for 
manual cell counting at 61-90 min and 91-150 min 
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and for biochemistry analyses. Due to the limited 
sample volume, biochemistry analyses were per-
formed only in the time delay of 91-150 min, in 
both uncentrifuged and centrifuged aliquots (Fig-
ure 1). Samples were centrifuged on an MPW-223e 
centrifuge (MPW Med. Instruments, Warsaw, Po-
land) for 10 minutes at 2000xg.
Cell counting
At the baseline, the EVD CSF cell count was per-
formed by two methods: manual and automated. 
Firstly, the total cells (TC) and red blood cells (RBC) 
were counted in native CSF using the Fuchs-
Rosenthal chamber. Total cells were differentiated 
to small and large lymphocytes, neutrophil granu-
locytes, phagocytes and disintegrated cells and 
results were expressed as a cell number/3x106/L 
(17). Counting was performed using Olympus BX41 
light microscope (Olympus, Tokyo, Japan) under 
the 400x magnification. 
The cell count was also performed in Body fluid 
(BF) mode on the Sysmex XE5000 haematology 
analyser (Sysmex Corporation, Kobe, Japan). The 
cell count in BF mode included: white blood cells 
(WBC), red blood cells (RBC), polymorphonuclear 
cells (PMN) and mononuclear cells (MN). Because 
of the limited sample volume, counting in Body 
fluid mode was not repeated at delayed time in-
tervals. White blood cells parameter corresponds 
to TC in the manual count. The results were ex-
pressed as a cell number/3 x106/L. 
Glucose, lactate and proteins measurement in CSF
Glucose, lactate and total protein concentrations 
were measured on Cobas 6000 c501 biochemistry 
analyser (Roche Diagnostics GmbH, Mannheim, 
Germany) with standard methods, using reagents 
GLUC3 (enzymatic reference method with hexoki-
nase), LACT2 (enzymatic method with lactate oxi-
dase) and TPUC3 (precipitating method with ben-
Figure 1. Schematic representation of the study design. Upon sample admission, EVD CSF was thoroughly mixed to achieve a ho-
mogenized sample. Routine testing of CSF included manual cell counting and biochemistry analyses in centrifuged sample. Addi-
tionally, automated cell counting and biochemistry analysis in uncentrifuged sample were performed. These results were used as 
baseline values for this study. The residual materials of EVD CSF were used for testing the effect of time delay and sample process-
ing on cell count and biochemistry tests. The tube with uncentrifuged residual sample was kept closed at room temperature (range 
22-26 °C) and was used for manual cell counting at 61-90 min and 91-150 min and for biochemistry analyses in uncentrifuged and 
centrifuged sample. Measurements included: cell counting (white blood cell count, red blood cell count, polymorphonuclear cells, 
mononuclear cells) and glucose, lactate and total proteins. CSF - cerebrospinal fluid. EVD - extraventricular drainage.
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Time interval of analysis
CSF cells (/3 x106/L) 0-60 minutes (baseline) 61-90 minutes P* 91-150 minutes P†
Total cell number 199 (82 - 573) 193 (82 - 583) 0.033 183 (56 - 581) < 0.001
Small lymphocytes 17 (4 - 132) 9 (3 - 114) 0.265 13 (2 - 124) 0.167
Large  lymphocytes 14 (5 - 36) 13 (4 - 43) 0.166 13 (4 - 33) 0.007
Neutrophil granulocytes 72 (8 - 495) 71 (9 - 498) 0.046 49 (12 - 496) < 0.001
Phagocytes 2 (0 - 5) 1 (0 - 6) 0.020 1 (0 - 4) 0.006
Disintegrated cells 7 (1 - 20) 7 (3 - 20) 1.000 10 (3 - 34) 0.016
Red blood cells 3630 (184 -13,055) 2990 (165 - 14,646) 0.923 3140 (149 - 13,415) 0.202
Values are presented as median (interquartile range). *Difference between baseline and 61-90 minutes time delay. †Difference 
between baseline and 91-150 minutes time delay. P < 0.05 was considered statistically significant.
Table 1. Values of manual cell counting in cerebrospinal fluid collected from extraventricular drainage systems (N = 32) at the base-
line and delayed time intervals
zethonium chloride), respectively (Roche Diagnos-
tics GmbH, Mannheim, Germany). For each ana-
lyte, quality control was performed daily in two 
levels using PreciControl ClinChem Multi 1 and 
PreciControl ClinChem Multi 2 (Roche Diagnostics 
GmbH, Mannheim, Germany), and Precinorm PUC 
and Precipath PUC controls (Roche Diagnostics 
GmbH, Mannheim, Germany). Coefficients of vari-
ations in the tested time period were within ana-
lytical requirements for imprecision.
Statistical analysis
Data were tested for normality using the Shapiro-
Wilk test. Data did not follow a normal distribution 
and were presented as median (interquartile range 
(IQR)). Statistical differences were tested using the 
Wilcoxon rank sum test for paired samples. Spear-
man correlation was performed as a post-hoc test 
to test whether the differences in biochemistry 
tests between centrifuged and uncentrifuged CSF 
are associated with the TC or RBC count. Compari-
sons of automated and manual cell counting 
methods were performed using Passing-Bablok 
regression, presented with regression equation 
and 95% confidence intervals (95% CI) for slope 
and intercept, and Bland Altman analysis. The fol-
lowing cell subgroups were compared: WBC and 
TC, PMN and neutrophil granulocytes, MN and the 
sum of small and large lymphocytes. A P value < 
0.05 was set as a level of statistical significance. 
Statistical analysis was performed using MedCalc 
Software v.17.4.4 (Ostendt, Belgium).
Results
A total number of 32 CSF samples collected from 
EVD system were included in the study. Median 
(IQR) of tested analytes at each time interval and 
sample processing status are summarized in Ta-
bles 1 and 2.
Throughout the tested period regarding the man-
ual counting, the number of RBCs (P = 0.202) and 
small lymphocytes (P = 0.167) remained un-
changed compared to the baseline values. Al-
ready, at 61-90 minutes interval, TC count (P = 
0.033), neutrophil granulocytes (P = 0.046) and 
phagocytes (P = 0.020) decreased compared to 
the baseline counting. Finally, at 91-150 minutes in-
terval, large lymphocytes decreased (P = 0.007) 
and the number of disintegrated cells increased (P 
= 0.016) compared to the baseline count (Table 1). 
In a comparison of the automated and manual 
method of cell counting, two EVD CSF samples 
were excluded from analysis: a sample with WBCs 
17,760/3 x106/L and a sample with 632,320/3 x106/L 
RBCs. These samples had extremely high cell 
counts, which would influence Passing-Bablok re-
gression analysis. Automated and manual meth-
ods for cell counting showed: the proportional dif-
ference for WBC [y = 13.68 (95% CI: - 6.82 to 32.26) 
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D* Glucose D* Lactate
0-60 min 91-150 min 0-60 min 91-150 min
Analyte r P† r P† r P† r P†
Total cell count 0.07 0.718 0.02 0.930 0.05 0.807 0.23 0.213
Red blood cells 0.29 0.106 0.14 0.449 0.25 0.163 0.09 0.636
*D = concentration (uncentrifuged EVD sample) - concentration (centrifuged EVD sample). †Spearman correlation test was 
performed, correlation coefficient (r) and corresponding P value are presented. EVD - extraventricular drainage. P < 0.05 was 
considered statistically significant.
Table 3. Correlation of manual total cell count and red blood cells count and the difference in concentrations of glucose and lactate 
in uncentrifuged and centrifuged extraventricular drainage samples at different time intervals
Time interval of analysis
0-60 min (baseline) 91-150 min
Analyte (units) Uncentrifuged Centrifuged P* Uncentrifuged Centrifuged P† P‡
Glucose 
(mmol/L) 3.63 (2.60 - 4.07) 3.70 (2.67 - 4.32) < 0.001 3.69 (2.67 - 4.12) 3.78 (2.69 - 4.33) 0.006 0.797
Lactate 
(mmol/L) 3.24 (2.37 - 4.37) 3.48 (2.46 - 4.76) < 0.001 3.18 (2.42 - 4.16) 3.25 (2.48 - 4.79) < 0.001 0.493
Total proteins 
(g/L) 0.71 (0.41 - 1.49) 0.68 (0.43 - 1.62) 0.249 0.69 (0.37 - 1.55) 0.65 (0.39 - 1.62) 0.316 0.866
Values are presented as median (interquartile range). *Difference between uncentrifuged and centrifuged samples at the baseline. 
†Difference between uncentrifuged and centrifuged samples 91-150 minutes time delay. ‡Difference of centrifuged sample at the 
baseline and centrifuged sample at 91-150 minutes time delay. P < 0.05 was considered statistically significant.
Table 2. The results of biochemistry analyses in uncentrifuged and centrifuged cerebrospinal fluid from extraventricular drainages 
at baseline and with the time delay
+ 1.17 (95% CI: 1.04 to 1.36)x, RBCs [y = - 41.49 (95% 
CI: - 208.39 to 58.15) + 1.19 (95% CI: 1.02 to 1.39)x 
and MN [y = 6.36 (95% CI: - 1.39 to 33.22) + 1.44 
(95% CI: 1.10 to 2.08)x, while PMN have both pro-
portional and constant difference [y = 11.21 (95% 
CI: 0.80 to 24.44) + 1.22 (95% CI: 1.05 to 1.52)x] (Fig-
ure 2). Bland Altman analysis shows that measure-
ments obtained by an automated method are sta-
tistically significantly higher compared to the 
manual count. Mean bias of automated method 
for WBC, RBC, MN and PMN are 133/3x106/L 4842/3 
x106/L, 69/3 x106/L and 93/3 x106/L, respectively. 
Automated method always overestimated the re-
sults compared to manual counting.
The results of biochemical tests in uncentrifuged 
EVD CSF samples were available very quickly with 
a median time of 16 min (IQR 6-28) from sample 
admission. Median time to results was 27 min (IQR 
22-37) for centrifuged samples. However, com-
pared to the centrifuged EVD CSF samples assayed 
within 60 minutes of sample admission, uncentri-
fuged samples had lower glucose (P < 0.001) and 
lactate (P < 0.001) concentration. Glucose (P = 
0.006) and lactate (P < 0.001) concentrations were 
also lower in uncentrifuged CSF samples com-
pared to centrifuged samples at the 91-150 min-
utes interval (Table 2). Differences in biochemistry 
tests between uncentrifuged and centrifuged 
tubes did not correlate with cell content (Table 3). 
Total protein concentration remained unchanged 
irrespective of the time delay (P = 0.866) and sam-
ple processing status (P = 0.249). The time delay in 
sample centrifugation had no statistically signifi-
cant effect on glucose and lactate concentrations 
(P = 0.797 and 0.493, respectively) (Table 2).
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Figure 2. The comparison results of automated and manual method of cell counting in cerebrospinal fluid collected from extraven-
tricular drainage systems. The following cell subgroups from automated and manual method, respectively, were compared using 
Pasing Bablok regression analysis and Bland Altman graph: WBC and TC (A,B); RBC from automated and manual counting (C,D); MN 
and the sum of small and large lymphocytes (E,F); PMN and neutrophil granulocytes (G,H). The analysis shows the proportional dif-
ference in WBC, RBC and MN, while PMN have both proportional and constant difference. Automated method significantly overes-
timates the results. Passing Bablok regression line (solid line), the confidence interval for the regression line (dashed lines) and iden-
tity line (x=y, dotted line) are shown. Bland Altman graph: mean difference (solid line), 95% confidence interval of mean difference 
(dashed and dotted line), ± 1.96 standard deviations of mean difference (dashed line), identity line (dotted line). WBC - white blood 
cells. TC - manual total cell count. RBC - red blood cells. MN - mononuclear cells. PMN - polymorphonuclear cells. NE - neutrophil 
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Discussion
Cerebrospinal fluid samples from EVD system are 
partially different from CSF samples obtained by 
lumbar puncture and represent a special category 
of biological material. The stability of different an-
alytes in such samples is not well established. We 
investigated the effect of time delay and sample 
processing on cell count and basic biochemistry 
results in these samples. 
Our results showed that a relatively short delay in 
cell counting (61-90 minutes) caused a statistically 
significant fall in total cell count and granulocyte 
count by manual method. These results are in ac-
cordance with previously reported results for CSF 
obtained by LP that indicated that the delay in 
WBC counting could produce false negative re-
sults in 40% of samples with pleocytosis and as 
high as in 86% of the samples with a mild eleva-
tion in WBC count (18). Also, the selective loss of 
granulocytes was observed thereby possibly im-
pacting clinical decision (18). Therefore, we strong-
ly recommend processing the CSF samples from 
EVD system within a time delay of maximum 60 
minutes. 
Manufacturer recommends measuring glucose in 
CSF immediately as such samples can be contami-
nated with bacteria and can often contain other 
cellular constituents.  Otherwise, storing the sam-
ple at 4 °C or - 20 °C is recommended (19). During 
the routine laboratory work delay in sample pro-
cessing is likely and in such scenario, the sample 
would probably be left at room temperature until 
analysis. We found that glucose, lactate and pro-
teins in EVD samples are stable even when the 
centrifugation is delayed for 2.5 hours and despite 
a relatively high cell number in most samples. Oth-
er published literature confirms our results. A 
study by Dujmovic and Deisenhammer proved 
glucose and lactate in centrifuged CSF samples are 
stable for 4 hours, at 4 °C (20). Results of an in vitro 
study suggest that the effect of RBC contribution 
on lactate concentration becomes significant only 
after 6 hours (21). Furthermore, the manufacturer 
declares lactate stability in CSF for 3 hours at room 
temperature and proteins one day at 15 - 25 °C 
(22,23). The stability of lactate and proteins in EVD 
samples up to 2.5 hours was confirmed in our 
study.
Analysing uncentrifuged EVD CSF samples is unac-
ceptable because glucose and lactate concentra-
tions were significantly lower compared to centri-
fuged samples. This effect was present regardless 
of time delay and was not associated with total 
cells or red blood cells count. Therefore, faster TAT 
cannot be achieved by omitting centrifugation, 
even in samples with low cell counts.
Due to increased use of automated methods for 
cell counting in CSF, especially in emergency ser-
vices, we analysed EVD samples at the baseline by 
both manual and automated methods, to estab-
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a substitute for each other. Contrary to previously 
reported studies comparing CSF samples collect-
ed by lumbar puncture, an automated and manual 
method for cell counting proved not to be compa-
rable when assaying CSF collected from EVD in 
our study (15,24–27). The reason for this disagree-
ment could be the interference of cell debris in 
such samples. One other study reported the re-
sults of the comparison of Sysmex XE 5000 and 
manual counting using ventricular samples col-
lected from EVD which showed both proportional 
and constant difference between methods, with 
some highly discrepant findings (14). These au-
thors argue that despite discrepant results due to 
interferences, such high WBC counts are still indic-
ative of infection (1,5,9,28). We were unable to find 
clinical decision limits for this material in the pub-
lished literature. For this reason we did not discuss 
the clinical significance of the method bias. Sever-
al studies propose that the increases in the daily 
CSF cell count are highly indicative of bacterial in-
fection (5,29). Therefore, patients are followed lon-
gitudinally and CSF parameters and clinical status 
combinedly assessed. In such cases, the high com-
parability of test results is especially important. Ac-
cordingly, the method should always be stated in 
the laboratory report if automated and manual 
counting methods are used interchangeably in 
routine practice for EVD CSF samples. 
Limitations of the present study include small 
sample size and uneven distribution of the meas-
urements that could influence the comparison of 
the manual and automated methods of cell count-
ing in EVD samples. This could also be the reason 
for the disagreement with the results of other 
studies performed in CSF collected by lumbar 
puncture. However, due to the difficulty in sam-
pling CSF from EVD, limited amount of the collect-
ed material, and the relatively long duration of the 
study, we consider that the included sample size is 
representative for the studied population. Further-
more, the information on time passed from the 
sampling to the laboratory was not available, and 
we were only able to investigate the effect of time 
delay in EVD samples within the laboratory. Due to 
the insufficient CSF volume, we were unable to 
test the effect of time delay in more time intervals. 
Therefore, we have limited our study design to test 
only the effect of 2.5 hours time delay on bio-
chemistry analytes and compared automated and 
manual cell counting only at the baseline.
In summary, our results confirmed that delay in 
cell counting in EVD CSF samples causes a signifi-
cant fall in total cell count and granulocyte count. 
Therefore, we recommend TAT for cell number 
analysis of maximum 60 minutes. Glucose, lactate 
and total proteins are stable in uncentrifuged EVD 
CSF samples meaning the eventual delay in sam-
ple processing would not influence analytical re-
sults, but samples have to be centrifuged prior to 
biochemistry analysis. Results of manual and auto-
mated counting methods are not comparable for 
EVD samples. It is therefore imperative to always 
use the same counting technique to obtain results 
which could be correctly longitudinally assessed.
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